Zhang, P., Zhang, X., Lang, J., Wu, S., Sun, Y., Wang, P., . . . Yi, J. (2024). Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: A propensity score matching real‐world study. Wiley. https://doi.org/10.1002/mco2.608
Cita Chicago Style (17a ed.)Zhang, Peng, et al. Epidermal Growth Factor Receptor‑targeted Antibody Nimotuzumab Combined with Chemoradiotherapy Improves Survival in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Real‐world Study. Wiley, 2024. https://doi.org/10.1002/mco2.608.
Cita MLA (9a ed.)Zhang, Peng, et al. Epidermal Growth Factor Receptor‑targeted Antibody Nimotuzumab Combined with Chemoradiotherapy Improves Survival in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Real‐world Study. Wiley, 2024. https://doi.org/10.1002/mco2.608.